Old Web
English
Sign In
Acemap
>
Paper
>
Is Oncotype DX Testing Necessary For Patients With Node Negative, Low-Grade Invasive Ductal Breast Carcinoma?
Is Oncotype DX Testing Necessary For Patients With Node Negative, Low-Grade Invasive Ductal Breast Carcinoma?
2021
M Ali
Daniza Mandich
M Assaad
Richard W. Cartun
Keywords:
Oncotype DX
recurrence risk
Oncotype DX Breast Cancer Assay
Medicine
endocrine therapy
Oncology
Internal medicine
Invasive Ductal Breast Carcinoma
Surgical pathology
adjuvant chemotherapy
node negative
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]